Clinical metabolomics in diagnosis and therapy of coronary artery disease

YIN Kunpeng; ZHENG Hao; XIE Binxin; LI Ping; ZHANG Lei; FAN Yong; ZHU Wei; QI Lianwen

doi:10.11665/j.issn.1000-5048.20170601

Journal of China Pharmaceutical University > 2017 > 48(6): 629-634. > DOI: 10.11665/j.issn.1000-5048.20170601

YIN Kunpeng, ZHENG Hao, XIE Binxin, LI Ping, ZHANG Lei, FAN Yong, ZHU Wei, QI Lianwen. Clinical metabolomics in diagnosis and therapy of coronary artery disease[J]. Journal of China Pharmaceutical University, 2017, 48(6): 629-634. DOI: 10.11665/j.issn.1000-5048.20170601

Citation:

PDF (1256 KB)

Clinical metabolomics in diagnosis and therapy of coronary artery disease

More Information

Graphical Abstract

Abstract

Abstract

Metabolomics, a hot field of research of life science in recent years, is to analyze endogenous small-molecule metabolites in biological samples for an overall understanding of the characteristics of metabolic disorders. A growing number of studies have confirmed the application of metabolomics for clinical diagnosis and treatment of diseases. “Metabolic fingerprint” of biological fluids can be employed for disease prevention, timely diagnosis, accurate treatment, prognostic assessment and drug discovery. Clinical metabolomics is to measure low-molecule-weight metabolites′ alterations of individuals in response to physiological stressors, disease processes, or drug therapy, aiming to discover potential biomarkers and drug targets. Coronary artery disease(CAD)is characterized as complex molecular events. Metabolic disturbances are involved in CAD progression. The application of metabolomics to CAD is an emerging field. Advances in metabolomics improve our knowledge on CAD in early diagnosis, prognostic prediction, and personalized therapy.
- clinical metabolomics,
- coronary arterydisease,
- metabolic biomarkers,
- advances

FullText(HTML)

References (45)

References

[1]	Zhao JX,Tian YX.Huang Di Nei Jing(黄帝内经)[M].Beijing:Jinghua Press,2013:314-320.
[2]	Zbek A,Junka A,Szymczyk P,et al.Metabolomics analysis of fungal biofilm development and of arachidonic acid-based quorum sensing mechanism[J].J Basic Microb,2017,57(5):428-439.
[3]	Lee YJ,Perdian DC,Song Z,et al.Use of mass spectrometry for imaging metabolites in plants[J].Plant J,2012,70(1):81-85.
[4]	Hong JH,Lee WC,Hsu YM,et al.Characterization of the biochemical effects of naphthalene on the mouse respiratory system using NMR-based metabolomics[J].J Appl Toxicol,2015,34(12):1379-1388.
[5]	Heather LC, Wang X, West JA, et al. A practical guide to metabolomic profiling as a discovery tool for human heart disease[J].J Mol Cell Cardiol,2013,55(2):2-11.
[6]	Kobayashi T,Nishiumi S,Ikeda A,et al.A novel serum metabolomics-based diagnostic approach to pancreatic cancer[J].Cancer Epidem Biomar,2013,22(4):571-579.
[7]	Floegel A,Stefan N,Yu Z,et al.Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach[J].Diabetes,2013,62(2):639-648.
[8]	Paglia G,Stocchero M,Cacciatore S,et al.An unbiased metabolomic investigation of the Alzheimer′s disease brain points to a dysregulation of the mitochondrial aspartate metabolism[J].J Proteome Res,2015,15(2):1334-1341.
[9]	Tang H,Wang Y.Metabonomics:a revolution in progress[J].Prog Biochem Biophys,2006,33(5):401-417.
[10]	Nicholson JK,Lindon JC,Holmes E.‘Metabonomics’:understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data[J].Xenobiotica,1999,29(11):1181-1189.
[11]	Brindle JT,Antti H,Holmes E,et al.Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using ¹H-NMR-based metabonomics[J].Nat Med,2002,8(12):1439-1444.
[12]	Fan Y,Li Y,Chen Y,et al.Comprehensive metabolomic characterization of coronary artery diseases[J].J Am Coll Cardiol,2016,68(12):1281-1293.
[13]	Nicholson JK,Buckingham MJ,Sadler PJ.High resolution 1H n.m.r.studies of vertebrate blood and plasma[J].Biochem J,1983,211(3):605-615.
[14]	Qiu QQ,Yan M,Li C.Advances in analytic technology of metabolomics [J].J Diagn Concepts Pract(诊断学理论与实践),2011,10(1):82-85.
[15]	Bathen TF,Sitter B,Sjøbakk TE,et al.Magnetic resonance metabolomics of intact tissue:a biotechnological tool in cancer diagnostics and treatment evaluation[J].Cancer Res,2010,70(17):6692-6696.
[16]	Bernini P,Bertini I,Luchinat C,et al.The cardiovascular risk of healthy individuals studied by NMR metabonomics of plasma samples[J].J Proteome Res,2011,10(11):4983-4992.
[17]	Soininen P,Kangas AJ,Würtz P,et al.Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics[J].Circ Cardiovasc Genet,2015,8(1):192-206.
[18]	Wang J,Yuan ZM,Kong HW,et al.Exploring the mechanism of Rhizoma coptidis in treating type II diabetes mellitus based on metabolomics by gas chromatography-mass spectrometry[J].Chin J Chromatogr(色谱),2012,30(1):8-13.
[19]	Tachibana C.What′s next in ′omics:the metabolome[J].Science,2014,345(6203):1519-1521.
[20]	Yong F,Xin Z,Xia TS,et al.Human plasma metabolomics for identifying differential metabolites and predicting molecular subtypes of breast cancer[J].Oncotarget,2016,7(9):9925-9938.
[21]	World Health Organization.Cardiovascular disease(CVDs)[EB/OL].(2017-05-01)[2017-11-13] .http://www.who.int/mediacentre/factsheets/fs317/en.
[22]	Moran A,Gu D,Zhao D,et al.Future cardiovascular disease in China Markov model and risk factor scenario projections from the coronary heart disease policy model-China [J].Circ Cardiocasc Qual Outcomes,2010,3(3):243-252.
[23]	Mertens A,Verhamme P,Bielicki JK,et al.Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice[J].Circulation,2003,107(12):1640-1646.
[24]	Falk E.Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis.Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi[J].Brit Heart J,1983,50(2):127-134.
[25]	Schwartz SM.Perspectives series:cell adhesion in vascular biology.Smooth muscle migration in atherosclerosis and restenosis[J].J Clin Invest,1997,99(12):2814-2817.
[26]	Jiang P.The Study on Metabolomics and pharmacokinetics of Shexiang Baoxin Pill(麝香保心丸代谢组学和代谢动力学研究)[D].Shanghai:The Second Military Medical University,2012.
[27]	Barba I,León GD,Martín E,et al.Nuclear magnetic resonance-based metabolomics predicts exercise-induced ischemia in patients with suspected coronary artery disease[J].Magnet Reson Med,2008,60(1):27-32.
[28]	Sabatine MS,Liu E,Morrow DA,et al.Metabolomic identification of novel biomarkers of myocardial ischemia[J].Circulation,2005,112(25):3868-3875.
[29]	Evans AM,Dehaven CD,Barrett T,et al.Integrated,nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems[J].Anal Chem,2009,81(16):6656-6667.
[30]	Forcisi S,Moritz F,Kanawati B,et al.Liquid chromatography-mass spectrometry in metabolomics research:mass analyzers in ultra high pressure liquid chromatography coupling[J].J Chromatogr A,2013,1292(5):51-65.
[31]	Lewis GD,Wei R,Liu E,et al.Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury[J].J Clin Invest,2008,118(10):3503-3512.
[32]	Li J,Yang YL,Li LZ,et al.Succinate accumulation impairs cardiac pyruvate dehydrogenase activity through GRP91-dependent and independent signaling pathways:therapeutic effects of ginsenoside Rb1[J].BBA-Mol Basis Dis,2017,1863(11):2835-2847.
[33]	Vary TC,Reibel DK,Neely JR.Control of energy metabolism of heart muscle[J].Annu Rev Physiol,1981,43(5):419-430.
[34]	Young LH,Mcnulty PH,Morgan C,et al.Myocardial protein turnover in patients with coronary artery disease.Effect of branched chain amino acid infusion[J].J Clin Invest,1991,87(2):554-560.
[35]	Drake KJ,Sidorov VY,Mcguinness OP,et al.Amino acids as metabolic substrates during cardiac ischemia[J].Exp Biol Med,2012,237(12):1369-1378.
[36]	Yang R,Dong J,Zhao H,et al.Association of branched-chain amino acids with carotid intima-media thickness and coronary artery disease risk factors[J].PLoS ONE,2014,9(6):e99598.
[37]	Yang R, Wang S, Sun L, et al. Association of branched-chain amino acids with coronary artery disease:a matched-pair case-control study[J].Nutr Metab Cardiovas,2015,25(10):937-942.
[38]	Bernini P,Bertini I,Luchinat C,et al.The cardiovascular risk of healthy individuals studied by NMR metabonomics of plasma samples[J].J Proteome Res,2011,10(11):4983-4992.
[39]	Patel MR,Peterson ED,Dai D,et al.Low diagnostic yield of elective coronary angiography[J].New Engl J Med,2010,362(10):886-895.
[40]	Wang Z,Elizabeth K,Bennett BJ,et al.Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease[J].Nature,2011,472(7341):57-63.
[41]	Erdmann CC.Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk[J].New Engl J Med,2013,368(17):1575-1584.
[42]	Tang WH,Hazen SL.The contributory role of gut microbiota in cardiovascular disease[J].J Clin Invest,2014,124(10):4204-4211.
[43]	Wang Z,Roberts AB,Buffa JA,et al.Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis[J].Cell,2015,163(7):1585-1595.
[44]	Suhre K,Shin SY,Petersen AK,et al.Human metabolic individuality in biomedical and pharmaceutical research[J].Nature,2011,477(7362):54-60.
[45]	Wishart DS.Emerging applications of metabolomics in drug discovery and precision medicine[J].Nat Rev Drug Discov,2016,15(7):473-484.

[1]	LI Yue, XU Kai, YANG Rui, YANG Huiying. Application of ultra-high performance convergence chromatography-tandem quadrupole time-of-flight mass spectrometry in the analysis of Span composition[J]. Journal of China Pharmaceutical University, 2024, 55(6): 742-749. DOI: 10.11665/j.issn.1000-5048.2024010502
[2]	LI Yan, JIA Huanhuan, HUANG Qing, YUAN Yaozuo, CHEN Minhui, ZHANG Jinlin. Impurity spectra of lansoprazole enteric-coated preparations by high performance liquid chromatography-high resolution orbital trap mass spectrometry[J]. Journal of China Pharmaceutical University, 2023, 54(5): 577-585. DOI: 10.11665/j.issn.1000-5048.2023042601
[3]	HU Zhaoliang, ZOU Wenyu, SONG Min, HANG Taijun, LU Yuting. Correlation between in-vivo mercury exposure from Cinnabaris and memory disorders in juvenile rat[J]. Journal of China Pharmaceutical University, 2023, 54(4): 483-489. DOI: 10.11665/j.issn.1000-5048.2023042603
[4]	YU Lili, CHU Tingting, HOU Chenzhi, WANG Youmei, DI Bin. Quantitative determination of 10 illicit drugs in wastewater by liquid-liquid extraction-ultra performance liquid chromatography-tandem mass spectrometry[J]. Journal of China Pharmaceutical University, 2021, 52(6): 707-712. DOI: 10.11665/j.issn.1000-5048.20210608
[5]	XIE Feng, LI Zhan-bin, TAN Hong, WANG Yan-jiao. Determination of chromium in capsule shells by ultrasonic wave promoting dissolution-graphite furnace atomic absorption spectrometry[J]. Journal of China Pharmaceutical University, 2012, 43(3): 281-282.
[6]	SHEN Wei-yang, ZHONG Shao-peng, CHEN Jian-qiu. Interaction between silicotungstic acid,silicon tungsten-cobalt heteropoly acid and bovine serum albumin by fluorescence spectrometry[J]. Journal of China Pharmaceutical University, 2011, 42(2): 131-135.
[7]	Determination of Arsenic in Chinese Herbal Extract by Flow Injection-Hydride Generation-Atomic Absorption Spectrometry[J]. Journal of China Pharmaceutical University, 2003, (4): 48-50.
[8]	Determination of Trace Arsenic in Spirulina plaensis Tablets by Flow Injection Hydride Generation Atomic Fluorescence Spectrometry[J]. Journal of China Pharmaceutical University, 1998, (6): 473-474.
[9]	Determination of Arsenic in Chinese Traditional Patent Drug XINLINGWAN by Zeeman Graphite Furnace Atomic Absorption Spectrometry[J]. Journal of China Pharmaceutical University, 1995, (2): 94-96.
[10]	Determination of 11 Metal Elements in Chinese Traditional Medicine by Use of Atomic Absorption Spectrophotometry[J]. Journal of China Pharmaceutical University, 1991, (1): 33-35.

Cited By

Get Citation

PDF

XML

Article views (995) PDF downloads (2335)

Turn off MathJax

Article Contents

Abstract

References

Clinical metabolomics in diagnosis and therapy of coronary artery disease

Abstract

References

Related Articles

Catalog

Clinical metabolomics in diagnosis and therapy of coronary artery disease

Abstract

References

Related Articles

Catalog

Export File

Citation

Format

Content